This paper summarizes recent work on the design and development of targeted polymeric
bioconjugates based on N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers …

An amino group containing cyclosporin A (CsA) derivative has been synthesized and
conjugated to N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer via an aromatic azo …

Data on the synthesis, physicochemical characterisation and in vitro and in vivo biological
properties of the new, nontargeted or antibody-targeted polymer–doxorubicin conjugates …

The concept of polymer–drug conjugates was proposed more than 30 years ago, and an N-
(2-hydroxypropyl) methacrylamide (HPMA) copolymer conjugate of doxorubicin covalently …

In this paper we describe the synthesis, physico-chemical characteristics and results of tests
of biological activity of polymer drugs based on conjugates of anti-cancer drug doxorubicin …

Over the past few decades, numerous polymer drug carrier systems are designed and
synthesized, and their properties are evaluated. Many of these systems are based on water …

ABSTRACT (N-(2-Hydroxypropyl) methacrylamide (HPMA)) copolymers have seen
extensive development as sophisticated lysosomotropic drug carriers. They can be used for …

N-(2-Hydroxypropyl) methacrylamide (HPMA)-lectin (wheat germ agglutinin (WGA), peanut
agglutinin (PNA)) drug conjugates for treatment of the pre-cancerous conditions ulcerative …

The aim of this study was to compare the properties and antitumor potential of a novel type
of antibody-targeted N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer-bound …

N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer conjugates for colon-specific
delivery of 9-aminocamptothecin (9-AC) were designed. They hold 9-AC bound via spacers …